Home›Stock Screener›Vimta Labs

Vimta Labs Share Price Today | Stock Price & Vimta Labs Share Screener

VIMTALABS Healthcare Technology
Live Share Price NSE
₹571.75
▼ -12.60 (-2.16%)
2026-10-05 00:00:00
Live Share Price BSE
₹571.30
▼ -12.40 (-2.12%)
2026-10-05 00:00:00

As of October 5, 2026, the live Vimta Labs share price (NSE: VIMTALABS) is ₹571.75 on NSE and ₹571.30 on BSE, down 2.16% from the previous close, with shares trading between ₹570.50 and ₹604.00 in today's trading session, and a 52-week range of ₹380.70–₹725.40. Check VIMTALABS 52-week chart for the annual price range and momentum. Use the Vimta Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Vimta Labs opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹95 and net income of ₹22, with EBITDA of ₹38, an operating margin of 37.0% and a profit margin of 23.2%.

Vimta Labs Market Cap ₹2,612.04 Cr.
VIMTALABS P/E Ratio (TTM) 35.09
Vimta Labs P/B Ratio 7.86
EPS (TTM) ₹18.51
Dividend Yield 0.21%
Debt to Equity 0.06
VIMTALABS 52 Week High ₹725.40
Vimta Labs 52 Week Low ₹380.70
Operating Margin 37.00%
Profit Margin 23.16%
VIMTALABS Revenue (TTM) ₹95.00
EBITDA ₹38.00
Net Income ₹22.00
Total Assets ₹400.00
Total Equity ₹320.00

Vimta Labs Share Price Chart

Track the current stock price of Vimta Labs with an interactive chart. Analyse VIMTALABS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Vimta Labs stock quote in one place.

The quote of ₹571.75 sits between the 52-week low of ₹380.70 and the 52-week high of ₹725.40, and the latest session moved -2.16% from the previous close.

Vimta Labs Company Profile - Fundamental Screener

Screen Vimta Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VIMTALABS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Technology industry, and it trades under ISIN INE579C01029.

Company Details

Classification

Sector Healthcare
Industry Healthcare Technology
Sub-Sector Healthcare Technology
Segment E

Identifiers and Leadership

ISIN INE579C01029

Vimta Labs Balance Sheet Screener

Screen VIMTALABS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2024, total assets were ₹400, up from ₹362 in 2023.

Latest statistics put total assets at ₹400 and shareholder funds at ₹320, with a leverage ratio of 0.06.

Item 2024 2023 2022 2021 2020

Assets

Total Assets 400 362 307 274 246
Current Assets 158 164 124 111 96
Fixed Assets 171 175 169 135 138

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 26 23 26 26 15
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 320 282 234 194 173
Share Capital 4 4 4 4 4
Reserves & Surplus 315 277 230 190 169

Vimta Labs Income Statement Screener - Profit & Revenue Analysis

Screen Vimta Labs income statement and profit fundamentals. Analyze VIMTALABS quarterly results. Vimta Labs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2024-Dec, revenue was ₹95 and net profit was ₹22, equal to earnings per unit of ₹9.65, at an operating margin of 37%.

In that period expenses were ₹57, interest cost ₹1 and tax ₹6. The next period listed, 2024-Sept, shows revenue of ₹85 and net profit of ₹15.

Item 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept 2022-Jun 2022-Mar 2021-Dec 2021-Sept 2021-Jun

Revenue and Expenses

Revenue 95 85 76 80 75 68 84 83 79 81 80 75 68 76 62
Expenses 57 57 51 55 53 50 59 58 56 55 55 51 47 57 45

Operating Costs and Margins

EBITDA 38 29 25 25 23 18 25 25 23 26 25 24 21 19 17
Operating Profit % 37.00% 33.00% 32.00% 31.00% 29.00% 24.00% 30.00% 30.00% 28.00% 32.00% 30.00% 31.00% 31.00% 25.00% 27.00%
Depreciation 10 8 8 8 8 9 9 8 8 8 7 7 6 6 6
Interest 1 0 1 1 1 1 0 0 1 1 1 1 0 0 0

Profit and Earnings

Profit Before Tax 28 20 17 16 14 8 16 17 14 18 17 16 16 13 11
Tax 6 5 4 4 3 2 4 4 4 5 5 4 4 3 3
Net Profit 22 15 12 12 10 6 12 13 10 13 12 12 12 10 8
EPS 9.65 6.88 5.54 5.58 3.61 2.86 5.51 5.73 4.62 5.97 5.45 5.36 5.28 4.41 3.65

Vimta Labs Cash Flow Screener - Liquidity Fundamentals

Screen VIMTALABS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2024-March, operating activities generated ₹61, and net cash flow was an outflow of ₹17.

Over the same period, investing activities used ₹76 and financing activities used ₹2.

Item 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities 61 88 59 37 24
Investing Activities -76 -57 -38 -32 -21

Financing and Net Cash

Financing Activities -2 -11 -17 -5 -1
Net Cash Flow -17 20 5 1 3

Vimta Labs Shareholding Pattern Screener

See Vimta Labs shareholding pattern with promoter, FII, and DII holdings. Check Vimta Labs promoter holding and ownership changes for VIMTALABS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 35.85%, foreign institutions 4.89%, domestic institutions 0.14% and the public 25.01%, spread across 51,623 shareholders.

The shareholder count was 51,623 in 2026-Mar, compared with 50,190 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 35.85% 35.67% 36.70% 36.67% 35.99% 35.90% 36.92% 36.89%

Institutional Investors

FII Holding 4.89% 4.42% 3.66% 3.49% 4.33% 4.59% 5.13% 5.16%
DII Holding 0.14% 0.37% 1.43% 1.42% 0.87% 0.11% 1.50% 1.49%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 25.01% 25.03% 25.17% 24.02% 24.62% 25.12% 23.08% 23.13%
Other Holding 34.11% 34.52% 33.03% 34.40% 34.18% 34.29% 33.37% 33.33%
Shareholder Count 51,623 50,190 26,183 29,867 55,933 54,467 18,550 19,054

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Vimta Labs. Vimta Labs dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹2.00 per unit for 2026-March, a yield of 0.34%, compared with ₹2.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹2.00, ₹2.00 and ₹2.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹2.00 0.34%
2025-March ₹2.00 0.53%
2024-March ₹2.00 0.40%
2023-March ₹2.00 0.90%
2022-March ₹2.00 1.27%
2021-March ₹2.00 1.27%
2020-March ₹0.00 0.00%
2019-March ₹2.00 6.70%
2018-March ₹2.00 2.01%
2017-March ₹0.00 0.00%

Vimta Labs Stock Index Membership - Nifty & Sensex

See which indices include Vimta Labs stock. Check VIMTALABS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 2 indices, including BSE INDEX BSE HC.

Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX SMLCAP.

Complete Index List

BSE INDEX BSE HC
BSE INDEX SMLCAP

Vimta Labs Market Events Screener - Corporate Actions

Get Vimta Labs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Vimta Labs stock events that may affect VIMTALABS share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated July 20, 2026, with a record date of July 20, 2026.

It is followed by Annual General Meeting dated June 25, 2026 and Dividend dated June 18, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-07-20 2026-07-20 Quarterly Result Announcement NA 1.17%
2026-06-25 2026-06-25 Annual General Meeting NA 26.23%
2026-06-18 2026-06-18 Dividend ₹ 2.00 /share 9.95%
2026-05-06 2026-05-06 Quarterly Result Announcement NA 9.23%
2026-01-28 2026-01-28 Quarterly Result Announcement NA -3.90%
2025-11-03 2025-11-03 Quarterly Result Announcement NA 8.45%
2025-07-17 2025-07-17 Quarterly Result Announcement NA 4.92%
2025-06-13 2025-06-13 Bonus 1:1 6.85%
2025-06-06 2025-06-06 Annual General Meeting NA -8.46%
2025-05-30 2025-05-30 Dividend ₹ 2.00 /share -9.68%
2025-04-28 2025-04-28 Quarterly Result Announcement NA 10.85%
2025-01-24 2025-01-24 Quarterly Result Announcement NA 1.52%
2024-11-08 2024-11-08 Quarterly Result Announcement NA 0.98%
2024-07-18 2024-07-18 Annual General Meeting NA 14.19%
2024-07-11 2024-07-12 Dividend ₹ 2.00 /share 4.52%

Vimta Labs Competitors Screener - Peer Stocks Comparison

Screen VIMTALABS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 9 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Syngene International 14,585 66.69 3,809 2.56% 317 31.20
Indegene 14,301 35.47 3,583 21.58% 401 53.26
Suven Life Sciences 8,711 -25.66 21 19.32% -276 34.07
Vimta Labs 2,612 35.09 322 0.22% 41 39.40
Bilcare 228 -36.26 764 -5.33% -17 51.60
TAKE 187 15.25 61 497.06% 4 27.68
Jeevan Scientific Technology 170 33.40 62 29.56% 2 62.97
Adeshwar Meditex 25 33.09 56 -33.10% 1 53.57
Vanta Bioscience 15 150.80 2 -13.33% 0 48.79

Vimta Labs Company Announcements - News & Reports Screener

Screen VIMTALABS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 1, 2026.

The next most recent announcements are dated September 16, 2026 and September 8, 2026.

Date Update Actions
2026-10-01 Closure of Trading Window -
2026-09-16 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS -
2026-09-08 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-02 Announcement under Regulation 30 (LODR)-Credit Rating -
2026-09-01 Clarification Regarding Increase In Volume Of Our Securities Across Exchanges. -
2026-09-01 Clarification sought from Vimta Labs Ltd -
2026-08-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-21 Intimation On Cyber Security Incident -
2026-07-28 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-07-28 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-07-24 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-07-21 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-20 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-07-20 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-07-20 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-07-20 Q1 FY- 2026-27 - Unaudited Financial Results. -
2026-07-20 Board Meeting Outcome for Q1 FY- 2026-27 - Unaudited Financial Results. -
2026-07-15 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-07-15 Board Meeting Intimation for Q1- FY 2026-27 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹571.75, within a 52-week range of ₹380.70 to ₹725.40. The P/E ratio is 35.09 and the P/B ratio is 7.86, with earnings per unit of ₹18.51. Market capitalisation stands at ₹2,612.04 Cr and the dividend yield is 0.21%. The company operates in the Healthcare sector, in the Healthcare Technology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 5 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.